Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

DebugIT · Detecting and Eliminating Bacteria UsinG Information Technologies

FP7Status: CLOSED1 January 200830 June 2012EU funding €6,414,915

In about half a century of antibiotic use, unexpected new challenges have come to light: fast emer-gence of resistances among pathogens, misuse and overuse of antibiotics; direct and indirect re-lated costs. Antimicrobial resistance results in escalating healthcare costs, increased morbidity and mortality and the emergence or reemergence of potentially untreatable pathogens. In this context of infectious diseases we will (1) detect patient safety issues, (2) learn how to prevent them and (3) actually prevent them in clinical cases. We will detect harmful patterns and trends using clinical and operational information from Clinical Information Systems (CIS). This will bedone through the 'view' of a virtualized Clinical Data Re-pository (CDR), featuring, transparent access to the original CIS and/or collection and aggregation of data in a local store. Text, image and structured data mining on individual patients as well as on populations will learn us informational and temporal patterns of patient harm. This knowledge will be fed into a Medical Knowledge Repository and mixed with knowledge coming from external sources (for example guidelines and evidences). After editing and validating, this knowledge will be used by adecision support and monitoring tool in the clinical environment to prevent patient safety issues and report on it.Outcomes and benefits, both clinical and economical will be measured and reported on. Innovation within this project lays in the virtualization of Clinical Data Repository through ontology mediation, the advanced mining techniques, the reasoning engine and the consolidation of all these techniques in a comprehensive but open framework. This framework will be implemented, focused on infectious diseases, but will be applicable for all sorts of clinical cases in the future.

Consortium · 15 organisations

coordinator

AGFA HEALTHCARE N.V.

BE · €1,553,339

participant

EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH

DE · €530,039

participant

Linköping University

SE · €685,546

participant

Quadrat N.V.

BE

participant

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

FR · €397,180

participant

UNIVERSITE DE GENEVE

CH · €550,317

participant

IZIP A.S.

CZ · €50,974

participant

MD ACCESS AS

CZ · €61,100

participant

AVERBIS GMBH

DE · €214,132

participant

LES HOPITAUX UNIVERSITAIRES DE GENEVE

CH · €891,976

participant

HAUTE ECOLE SPECIALISEE DE SUISSE OCCIDENTALE

CH · €324,535

participant

UNIVERSITY COLLEGE LONDON

€501,395

participant

GAMA/SOFIA LTD

BG · €62,352

participant

UNIVERSITAETSKLINIKUM FREIBURG

DE · €341,503

participant

TECHNOLOGIKO EKPEDEFTIKO IDRIMA LAMIAS

EL · €250,527

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.